Literature DB >> 16335636

Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.

A Karimi1, A Arjomandi, A Alborzi, M Rasouli, M R Kadivar, B Obood, B Pourabbas.   

Abstract

An outbreak of measles due to secondary vaccine failure prompted this investigation into the prevalence of measles antibody in children. We studied 608 children in 7 different age groups: 6, 9, 14 and 18 months and 6, 10 and 15 years. Children in the 2 youngest groups received no vaccination; the rest were vaccinated at 9 months and 15 months. The 15-year-old age group received an additional vaccination. Transplacental measles antibody (Ab) decreased from 10.0% at 6 months to 0% at 9 months. Measles Ab was positive in 52.9% (14 months), 89.4% (18 months), 60.8% 96 years), 45.0% (10 years) and 96.8% (15 years). To increase Ab levels, a booster vaccination is recommended, administered either with the second DPT booster or at pre-high school age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16335636

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  3 in total

1.  Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran.

Authors:  Shahrokh Izadi; Seyed Mohsen Zahraei; Talat Mokhtari-Azad
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

2.  A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents.

Authors:  Zary Nokhodian; Behrooz Ataei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Seyed Mohsen Zahraei; Roya Kelishadi
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

3.  Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.

Authors:  Hana Saffar; Maryam Khalifeloo; Mohammad-Jafar Saffar; Alireza Abdollahi; Mohammad-Reza Parsaei; Gholam-Reza Ghorbani; Samaneh Salarvand; Mohsen Aarabi
Journal:  BMC Infect Dis       Date:  2021-03-25       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.